BONE MARROW RETICULIN FIBROSIS AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED IN THE ERA OF NOVEL AGENTS

被引：0
|
作者：
Suriu, C. [1 ,2 ]
Livne, M. [2 ]
Sonkin, V. [1 ]
Akria, L. [1 ,2 ]
Barhoum, M. [1 ]
Braester, A. [1 ,2 ]
机构：
[1] Galilee Med Ctr, Nahariyya, Israel
[2] Bar Ilan Univ, Fac Med Galilee, Safed, Israel
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1976
引用
收藏
页码：793 / 793
页数：1
相关论文
共 50 条
  • [21] The Albumin and Monoclonal Protein Ratio as Prognostic Marker for Multiple Myeloma in the Era of Novel Agents
    Kadar, Katalin
    Wolf, Krisztina
    Tabori, Judit
    Karadi, Istvan
    Varkonyi, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (03) : 557 - 561
  • [22] POLYCLONAL SERUM IGM AS A PROGNOSTIC MARKER IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Napolitano, M.
    Montante, C.
    Saccullo, G.
    Mancuso, S.
    Cariccio, M. R. Lanza
    Malato, A.
    Fabbiano, F.
    Lucchesi, A.
    Pagan, F.
    Conticello, C.
    Mannina, D.
    Di Raimondo, F.
    Siragusa, S.
    HAEMATOLOGICA, 2016, 101 : 546 - 547
  • [23] Prognostic value of bone marrow angiogenesis in newly diagnosed multiple myeloma: A comparison with conventional prognostic factors.
    Kumar, S
    Haug, JL
    Wellik, L
    Witzig, TE
    Lust, JA
    Kline, M
    Lacy, MQ
    Dispenzieri, A
    Gertz, MA
    Greipp, PR
    Rajkumar, SV
    BLOOD, 2005, 106 (11) : 360B - 360B
  • [24] Bone marrow fibrosis in patients with multiple myeloma
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 257 - 258
  • [25] The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
    Chakraborty, R.
    Muchtar, E.
    Kumar, S.
    Buadi, F. K.
    Dingli, D.
    Dispenzieri, A.
    Hayman, S. R.
    Hogan, W. J.
    Kapoor, P.
    Lacy, M. Q.
    Leung, N.
    Gertz, M. A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (01) : 34 - 40
  • [26] A meta-analysis of autologous transplantation for newly diagnosed multiple myeloma in the era of novel agents
    Su, Baohua
    Zhu, Xu
    Jiang, Yina
    Wang, Lida
    Zhao, Ningning
    Ran, Xuehong
    Zhen, Xiaobin
    Guo, Hui
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1381 - 1388
  • [27] The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
    R Chakraborty
    E Muchtar
    S Kumar
    F K Buadi
    D Dingli
    A Dispenzieri
    S R Hayman
    W J Hogan
    P Kapoor
    M Q Lacy
    N Leung
    M A Gertz
    Bone Marrow Transplantation, 2017, 52 : 34 - 40
  • [28] Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents
    Cibeira, M. Teresa
    Rozman, Maria
    Segarra, Marta
    Lozano, Esther
    Rosinol, Laura
    Cid, Maria C.
    Filella, Xavier
    Blade, Joan
    CYTOKINE, 2008, 41 (03) : 244 - 253
  • [29] Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents
    Hagiwara, Shotaro
    Hirai, Risen
    Nakamura, Miki
    Tanimura, Akira
    Takeshita, Masataka
    Miwa, Akiyoshi
    BLOOD, 2013, 122 (21)
  • [30] Bone Marrow Fibrosis In Patients With Multiple Myeloma: A New Prognostic Factor For Survival?
    Hallgrimsdottir, Tinna
    Porwit, Anna
    Bjoerkholm, Magnus
    Rossmann, Eva
    Steingrimsdottir, Hlif
    Lund, Sigrun Helga
    Kristinsson, Sigurdur Y.
    BLOOD, 2013, 122 (21)
12345